These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 32705357)

  • 41. Sickle cell disease: a review for the internist.
    Pinto VM; Balocco M; Quintino S; Forni GL
    Intern Emerg Med; 2019 Oct; 14(7):1051-1064. PubMed ID: 31385153
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Low dose ketamine versus morphine for acute severe vaso occlusive pain in children: a randomized controlled trial.
    Lubega FA; DeSilva MS; Munube D; Nkwine R; Tumukunde J; Agaba PK; Nabukenya MT; Bulamba F; Luggya TS
    Scand J Pain; 2018 Jan; 18(1):19-27. PubMed ID: 29794277
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neuropathic Pain in Cancer: What Are the Current Guidelines?
    Mulvey MR; Paley CA; Schuberth A; King N; Page A; Neoh K
    Curr Treat Options Oncol; 2024 Sep; 25(9):1193-1202. PubMed ID: 39102168
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Description of criteria for near miss in high-complexity obstetric population with sickle cell anemia: an observational study.
    Burgos Luna JM; Páez Rúa DM; Ruiz Ordoñez I; Fernández PA; Escobar Vidarte MF
    J Matern Fetal Neonatal Med; 2020 Mar; 33(6):941-946. PubMed ID: 30231783
    [No Abstract]   [Full Text] [Related]  

  • 45. Sickle cell disease in the emergency department.
    Lovett PB; Sule HP; Lopez BL
    Emerg Med Clin North Am; 2014 Aug; 32(3):629-47. PubMed ID: 25060254
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An Electronic Teaching Module for Improving Knowledge of Self-Management of Vaso-Occlusive Pain Crises in Patients With Sickle Cell Disease: Pilot Questionnaire Study.
    Tam T; Baer MR; Hsu LL; Law JY
    JMIR Mhealth Uhealth; 2019 Jun; 7(6):e13501. PubMed ID: 31223120
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Endothelin receptor antagonists in sickle cell disease: A promising new therapeutic approach.
    Fox BM; Kasztan M
    Life Sci; 2016 Aug; 159():15-19. PubMed ID: 27049871
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Targeting novel mechanisms of pain in sickle cell disease.
    Tran H; Gupta M; Gupta K
    Blood; 2017 Nov; 130(22):2377-2385. PubMed ID: 29187376
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The management of sickle cell pain in the emergency department: a priority for health systems.
    Po' C; Colombatti R; Cirigliano A; Da Dalt L; Agosto C; Benini F; Zanconato S; Sainati L
    Clin J Pain; 2013 Jan; 29(1):60-3. PubMed ID: 22751027
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pain Management Issues as Part of the Comprehensive Care of Patients with Sickle Cell Disease.
    Lakkakula BVKS; Sahoo R; Verma H; Lakkakula S
    Pain Manag Nurs; 2018 Dec; 19(6):558-572. PubMed ID: 30076112
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Presence of neuropathic pain as an underlying mechanism for pain associated with cold weather in patients with sickle cell disease.
    Molokie RE; Wang ZJ; Wilkie DJ
    Med Hypotheses; 2011 Oct; 77(4):491-3. PubMed ID: 21763079
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pain syndromes in sickle cell disease: an update.
    Niscola P; Sorrentino F; Scaramucci L; de Fabritiis P; Cianciulli P
    Pain Med; 2009 Apr; 10(3):470-80. PubMed ID: 19416438
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Psychosocial and Functional Outcomes in Youth With Chronic Sickle Cell Pain.
    Sil S; Cohen LL; Dampier C
    Clin J Pain; 2016 Jun; 32(6):527-33. PubMed ID: 26379074
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sickle Cell Disease: Considerations for Acute Pain Management in the Hematology-Oncology Ambulatory Setting.
    Pohl E
    Clin J Oncol Nurs; 2021 Oct; 25(5):605-607. PubMed ID: 34533511
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Management of Postherniorrhaphy Chronic Neuropathic Groin Pain: A Role for Dorsal Root Ganglion Stimulation.
    Liem L; Mekhail N
    Pain Pract; 2016 Sep; 16(7):915-23. PubMed ID: 26914499
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Home management of pain in sickle cell disease: a daily diary study in children and adolescents.
    Dampier C; Ely E; Brodecki D; O'Neal P
    J Pediatr Hematol Oncol; 2002 Nov; 24(8):643-7. PubMed ID: 12439036
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Non-pharmacologic management of sickle cell pain.
    Bodhise PB; Dejoie M; Brandon Z; Simpkins S; Ballas SK
    Hematology; 2004 Jun; 9(3):235-7. PubMed ID: 15204105
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Barriers to effective pain management in sickle cell disease.
    Wright K; Adeosum O
    Br J Nurs; 2009 Feb 12-25; 18(3):158-61. PubMed ID: 19223799
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Management of Acute Complications of Sickle Cell Disease.
    Shamayeva S; Morocco P
    Pediatr Ann; 2024 Feb; 53(2):e47-e51. PubMed ID: 38302123
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neuropathic pain.
    Kerstman E; Ahn S; Battu S; Tariq S; Grabois M
    Handb Clin Neurol; 2013; 110():175-87. PubMed ID: 23312640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.